Michael Thomas Henderson, CEO: Apogee Therapeutics APGE Sell · Filed 25/11/13

Trade details

Type: Insider sale
Amount: $932,830.36
Shares · price: 14,774 sh · $63.14 a share
Held after: 1,274,873 sh
Stock: Apogee Therapeutics APGE
Person: Michael Thomas HendersonCEO
Trade date: 25/11/13
Filed: 25/11/13
Days to filing: 0 days

Sold 1.1% of holdings

Share of holding sold: 1.1%

Apogee Therapeutics trades, last 26 weeks

What else happened in Apogee Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/14~25/12/13

Michael Thomas Henderson's recent trades

Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$10.6M
80,000 sh
$10.6M
Filed 06/24
Traded 06/22
Michael Thomas HendersonDirector
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$2M
20,000 sh
$2M
Filed 06/23
Traded 06/22
Michael Thomas HendersonDirector
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$1.8M
20,000 sh
$1.8M
Filed 06/22
Traded 06/22
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$633.6K
7,654 sh
$633.6K
Filed 06/12
Traded 06/10
Michael Thomas HendersonCEO
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 plan
Apogee Therapeutics
APGE
$556.6K
6,770 sh
$556.6K
Filed 06/12
Traded 06/10